Geopolitics Alpha

Live · last trade · ETF proxies, Alpaca IEX

Insmed shares jump more than 18% on report Sanofi is weighing acquisition

Published . Updated .

Key takeaways

  • This report does not map to a usual set of affected companies.
  • Exposed: INSM, SNY, XLV, LLY, JNJ
  • Market reaction: INSM +16.2% on the day (still updating); SNY −2.6% on the day (still updating); NVS −2.2% on the day (still updating)

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

GEOPOLITICS ALPHAInsmed shares jump more than 18%on report Sanofi is weighingacquisitionINSMSNYGEOPOLITICS ALPHA

This report does not map to a usual set of affected companies.

Directly affected

  • INSM Insmed+12.2% 30d

    Named in this report.

  • SNY Sanofi

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Insmed belongs to, so it often moves with news about it.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.

  • ABBV AbbVie+12.0% 30d

    AbbVie is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck+3.5% 30d

    Merck is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories+10.0% 30d

    Abbott Laboratories is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.

  • NVS Novartis AG

    Novartis AG is a peer of Sanofi in pharmaceutical preparations; rivals often move on the same news.

  • AZN AstraZeneca+19.9% 30d

    AstraZeneca is a peer of Sanofi in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
INSM-1.49%+2.61%base+16.20%after closeafter closeafter close
SNY+2.84%+2.72%base-2.61%after closeafter closeafter close
XLV+3.66%+3.71%base-2.06%after closeafter closeafter close
LLY+3.43%+3.72%base-0.94%after closeafter closeafter close
JNJ+3.98%+3.63%base-2.14%after closeafter closeafter close
ABBV+2.96%+2.98%base-1.08%after closeafter closeafter close
MRK+6.65%+4.90%base-1.79%after closeafter closeafter close
ABT+2.66%+2.90%base+0.24%after closeafter closeafter close
NVS+3.22%+3.16%base-2.18%after closeafter closeafter close
AZN+3.14%+2.95%base-1.41%after closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Insmed shares jump more than 18% on report Sanofi is weighing acquisition Investing.com

Source: Investing.com

This story

CompanyWhenMoveStatus
ABBVthat day-1.08%still updating
ABBVthree days earlier+2.98%final price
ABBVfive days earlier+2.96%final price
ABTthat day+0.24%still updating
ABTthree days earlier+2.90%final price
ABTfive days earlier+2.66%final price
AZNthat day-1.41%still updating
AZNthree days earlier+2.95%final price
AZNfive days earlier+3.14%final price
INSMthat day+16.20%still updating
INSMthree days earlier+2.61%final price
INSMfive days earlier-1.49%final price
JNJthat day-2.14%still updating
JNJthree days earlier+3.63%final price
JNJfive days earlier+3.98%final price
LLYthat day-0.94%still updating
LLYthree days earlier+3.72%final price
LLYfive days earlier+3.43%final price
MRKthat day-1.79%still updating
MRKthree days earlier+4.90%final price
MRKfive days earlier+6.65%final price
NVSthat day-2.18%still updating
NVSthree days earlier+3.16%final price
NVSfive days earlier+3.22%final price
SNYthat day-2.61%still updating
SNYthree days earlier+2.72%final price
SNYfive days earlier+2.84%final price
XLVthat day-2.06%still updating
XLVthree days earlier+3.71%final price
XLVfive days earlier+3.66%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100Price not final

“Insmed shares jump more than 18% on report Sanofi is weighing acquisition” scores 12 out of 100. The score uses 1 source. The price is not final yet.